No Data
Presentation materials for the second quarter earnings conference of the fiscal year ending March 2025.
Announcements of individual stocks for participation in "JAPAN BUILD - Advanced Technology Exhibition for Architecture -" ~ Nano ceramics changing dehumidification ~ Aiming to promote the spread of "energy-saving type" desiccant air conditioners that cont
November 1st [Today's Investment Strategy]
[FISCO Selected Stocks] [Material Stocks] SCREEN Holdings <7735> 10,030 yen (10/31) Engaged in semiconductor manufacturing equipment such as wafer cleaning equipment. The earnings forecast for the fiscal year ending March 2025 has been revised upward. Operating profit is expected to be 113.5 billion yen (an increase of 20.5% from the previous year). It has been raised by about 8% from the previous forecast. This is the second upward revision of the full-year forecast for this fiscal year. The upward revision was due to factors such as the first-half operating profit of 58.2 billion yen (a 51.1% increase from the previous year), exceeding the previous forecast of 53 billion yen. "Year
Keep an eye on Mitsubishi Electric and Screen HD, while Fujitsu and Ibiden are sluggish.
In the US stock market on October 31st, the NY Dow closed down 378.08 points at 41,763.46, the NASDAQ composite index closed down 512.78 points at 18,095.15, and the Chicago Nikkei 225 futures traded in Osaka were down 710 yen at 38,350 yen compared to the daytime session in Japan. The exchange rate was 1 dollar = 152.00-10 yen. In today's Tokyo market, Mitsubishi Electric <6503> turned to profit with a 30.1% increase in operating profit from a 3.8% decrease in the first quarter, and another company showed an increase in operating profit with a 12.0% increase in the first half and a 7.3% decrease in the first quarter.
Canon Inc-spons adr, 3Q operating profit increased by 14.4% to 296.6 billion yen.
Canon Inc-Spons ADR <7751> announced its third quarter financial results for the fiscal year ending December 2024, with revenue increasing by 7.3% year-on-year to 3 trillion 236.1 billion 11 million yen, operating profit increasing by 14.4% to 296.6 billion 38 million yen. The gross profit margin increased by 0.8 points from the same period last year to 47.8%, due to cost reductions and favorable product mix, with gross profit also increasing by 7.1% year-on-year to 516.4 billion yen. [Positive evaluation] Takeda Pharmaceuticals Mid-Term <4502> | <7735> S
Start activities at japan's largest open innovation base, "STATION Ai".
No Data
No Data